Mark Bloch
Impact in
- Emergency Medicine top 1%
- HIV-related health complications and treatments
- Hepatology top 2%
- Hepatitis C virus research
Papers in
-
- HIV-related health complications and treatments 11
-
- Hepatitis C virus research 6
- Co-authors
- Janaki Amin (5 shared papers)Andrew D Carr (5 shared papers)Sean Emery (4 shared papers)Allison M. Martin (3 shared papers)David A. Cooper (1 shared paper)H. Ralph Schumacher (1 shared paper)Naomi Schlesinger (2 shared papers)Alexander K.-L. So (2 shared papers)
- Journals
- HIV Medicine (4 papers)Lara D. Veeken (3 papers)AIDS (3 papers)The Lancet HIV (3 papers)Clinical Infectious Diseases (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mark Bloch
33 papers receiving 2k citations
Mark Bloch's Hit Papers
Peers
Comparison fields: 5 of 78
- Emergency Medicine 428
- Hepatology 340
- Infectious Diseases 662
- Virology 90
- Nephrology 190
Countries citing papers authored by Mark Bloch
This map shows the geographic impact of Mark Bloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bloch more than expected).
Fields of papers citing papers by Mark Bloch
This network shows the impact of papers produced by Mark Bloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bloch. The network helps show where Mark Bloch may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Bloch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study Hit paper breakdown → | 2018 | 304 |
| 2 | 2012 | 276 | |
| 3 | 2015 | 260 | |
| 4 | 2004 | 222 | |
| 5 | 2009 | 194 | |
| 6 | 2000 | 88 | |
| 7 | 2021 | 85 | |
| 8 | 2021 | 82 | |
| 9 | 2001 | 74 | |
| 10 | 2019 | 60 | |
| 11 | 2014 | 59 | |
| 12 | 2005 | 46 | |
| 13 | 2010 | 45 | |
| 14 | 1973 | 40 | |
| 15 | 2012 | 39 | |
| 16 | 1972 | 37 | |
| 17 | 2007 | 36 | |
| 18 | 2008 | 28 | |
| 19 | 2010 | 21 | |
| 20 | 1974 | 17 |
About Mark Bloch
Mark Bloch is a scholar working on Emergency Medicine, Hepatology, Rheumatology, Infectious Diseases and Virology, having authored 37 papers that have together received 2.1k indexed citations. Recurring topics across this work include HIV-related health complications and treatments (11 papers), Hepatitis C virus research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers), HIV/AIDS drug development and treatment (3 papers), HIV/AIDS Research and Interventions (2 papers), HIV Research and Treatment (2 papers), Herpesvirus Infections and Treatments (2 papers) and Gout, Hyperuricemia, Uric Acid (2 papers). The work is most often cited by research in Emergency Medicine (428 citations), Hepatology (340 citations), Infectious Diseases (662 citations), Virology (90 citations) and Nephrology (190 citations). Mark Bloch has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Janaki Amin, Andrew D Carr, Sean Emery, Allison M. Martin, David A. Cooper, H. Ralph Schumacher, Naomi Schlesinger, Alexander K.-L. So, Dominik Richard and Valda Murphy. Their work appears in journals such as HIV Medicine, Lara D. Veeken, AIDS, The Lancet HIV and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.